Lowest Price Guaranteed
Pages
187
Last Updated
July 2026
View Count
5735
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Marget Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
5.1. Chapter Overview
5.2. Executive Summary: Market Landscape
5.3. Executive Summary: Mergers and Acquisitions
5.4. Executive Summary: Clinical Trial Analysis
5.5. Executive Summary: Market Forecast and Opportunity Analysis
6. INTRODUCTION
6.1. Chapter Overview
6.2. Medical Devices: An Overview
6.2.1. History of Medical Devices
6.2.2. Classification of Medical Devices
6.3. Medical Device Manufacturing
6.3.1. Challenges Associated with Medical Device Manufacturing
6.3.2. Role of CMOs in Medical Device Manufacturing
6.3.3. Role of Automation in Medical Device Manufacturing Process
6.4. Historical Timeline for Medical Device CMOs
6.5. Services Offered by Medical Device CMOs
6.6. Advantages Offered by Medical Device CMOs
6.7. Risks associated with Outsourcing to CMOs
6.8. Key Considerations
6.9. Concluding Remarks
7. REGULATORY LANDSCAPE FOR MEDICAL DEVICES
7.1. Chapter Overview
7.2. General Regulatory Guidelines for Medical Devices
7.3. Regulatory Landscape in North America
7.3.1. The US Scenario
7.3.1.1. Regulatory Authority
7.3.1.2. Review / Approval Process
7.3.2. The Canadian Scenario
7.3.2.1. Regulatory Authority
7.3.2.2. Review / Approval Process
7.4. Regulatory Landscape in Europe
7.4.1. Overall Scenario
7.4.1.1. Overall Regulatory Authorities
7.4.1.2. Review / Approval Process
7.4.2. Case Study: Brexit- The UK Scenario
7.5. Regulatory Landscape in Asia-Pacific
7.5.1. The Chinese Scenario
7.5.1.1. Regulatory Authority
7.5.1.2. Review / Approval Process
7.5.2. The Japanese Scenario
7.5.2.1. Regulatory Authority
7.5.2.2. Review / Approval Process
7.5.3. The Australian Scenario
7.5.3.1. Regulatory Authority
7.5.3.2. Review / Approval Process
7.6. Comparison of Regional Regulatory Environment
8. MARKET LANDSCAPE: MEDICAL DEVICE CONTRACT MANUFACTURERS OFFERING THERAPEUTIC DEVICES
8.1. Chapter Overview
8.2. Medical Device Contract Manufacturers Offering Therapeutic Devices: Overall Market Landscape
8.2.1. Analysis by Year of Establishment
8.2.2. Analysis by Company Size
8.2.3. Analysis by Location of Headquarters
8.2.4. Analysis by Location of Manufacturing Facilities
8.2.5. Analysis by Scale of Operation
8.2.6. Analysis by Class of Medical Device
8.2.7. Analysis by Type of Material Handled
8.2.8. Analysis by Type of Production Service Offered
8.2.9. Analysis by Type of Post-Production Service Offered
8.2.10. Analysis by Type of Additional Service Offered
9. MARKET LANDSCAPE: MEDICAL DEVICE CONTRACT MANUFACTURERS OFFERING DRUG DELIVERY DEVICES
9.1. Chapter Overview
9.2. Medical Device Contract Manufacturers Offering Drug Delivery Devices: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Analysis by Location of Manufacturing Facilities
9.2.5. Analysis by Scale of Operation
9.2.6. Analysis by Class of Medical Device
9.2.7. Analysis by Type of Material Handled
9.2.8. Analysis by Type of Production Service Offered
9.2.9. Analysis by Type of Post-Production Service Offered
9.2.10. Analysis by Type of Additional Service Offered
10. MARKET LANDSCAPE: MEDICAL DEVICE CONTRACT MANUFACTURERS OFFERING DIAGNOSTIC DEVICES
10.1. Chapter Overview
10.2. Medical Device Contract Manufacturers Offering Diagnostic Devices: Overall Market Landscape
10.2.1. Analysis by Year of Establishment
10.2.2. Analysis by Company Size
10.2.3. Analysis by Location of Headquarters
10.2.4. Analysis by Location of Manufacturing Facilities
10.2.5. Analysis by Scale of Operation
10.2.6. Analysis by Class of Medical Device
10.2.7. Analysis by Type of Material Handled
10.2.8. Analysis by Type of Production Service Offered
10.2.9. Analysis by Type of Post-Production Service Offered
10.2.10. Analysis by Type of Additional Service Offered
11. MARKET LANDSCAPE: MEDICAL DEVICE CONTRACT MANUFACTURERS OFFERING CATHETERS AND STENT DELIVERY DEVICES, AND OTHER DEVICES
11.1. Chapter Overview
11.2. Medical Device Contract Manufacturers Offering Catheters and Stent Delivery Devices, and Other Devices: Overall Market Landscape
11.2.1. Analysis by Year of Establishment
11.2.2. Analysis by Company Size
11.2.3. Analysis by Location of Headquarters
11.2.4. Analysis by Location of Manufacturing Facilities
11.2.5. Analysis by Scale of Operation
11.2.6. Analysis by Class of Medical Device
11.2.7. Analysis by Type of Material Handled
11.2.8. Analysis by Type of Production Service Offered
11.2.9. Analysis by Type of Post-Production Service Offered
11.2.10. Analysis by Type of Additional Service Offered
12. REGIONAL CAPABILITY ANALYSIS
12.1. Chapter Overview
12.2. Methodology
12.3. Medical Device Contract Manufacturers: Regional Capability Analysis
12.3.1. Regional Capability: Small Players Based in North America (Peer Group I)
12.3.2. Regional Capability: Mid-sized Players Based in North America (Peer Group II)
12.3.3. Regional Capability: Large and Very Large Players Based in North America (Peer Group III)
12.4. Concluding Remarks
13. COMPANY PROFILES
13.1. Chapter Overview
13.2. Cadence
13.2.1. Company Overview
13.2.2. Medical Device Contract Manufacturing Services Portfolio
13.2.3. Recent Developments and Future Outlook
* Similar details are presented for other companies mentioned below (based on information in the public domain)
13.3. Coastline International
13.4. Medical Murray
13.5. Sanmina
13.6. StarFish Medical
13.7. Tessy Plastics
14. SUPPLY CHAIN ANALYSIS
14.1. Chapter Overview
14.2. Overview of the Medical Device Supply Chain
14.3. Factors Affecting the Medical Device Supply Chain
14.4. Key Performance Indicators
14.5. Supply Chain Improvement Strategies
14.5.1. Optimization of Supply Chain Capabilities
14.5.2. Visible Supply Chain and Related Advantages
14.5.2.1. Augmenting Supply Chain Visibility Through Digitalization
14.5.2.2. Benefits of Digital Supply Chain
14.6. Effects of Supply Chain Optimization
14.7. Cost Analysis
14.7.1. Production-related Costs
14.7.1.1. Labor Costs
14.7.1.2. Raw Materials Related Costs
14.7.1.3. Regulatory Compliance
14.7.1.4. Technology-related Costs
14.7.2. Supply Chain-related Costs
14.7.2.1. Local Presence
14.7.2.2. Geopolitical Risk
14.7.2.3. Logistics
15. MERGERS AND ACQUISITIONS
15.1. Chapter Overview
15.2. Merger and Acquisition Models
15.3. Medical Device Contract Manufacturing: Mergers and Acquisitions
15.3.1. Analysis by Year of Deal
15.3.2. Analysis by Type of Deal
15.3.3. Analysis by Year and Type of Deal
15.3.4. Analysis by Geography
15.3.4.1. Local and International Deals
15.3.4.2. Intracontinental and Intercontinental Deals
15.3.5. Most Active Players: Analysis by Number of Deals Signed
16. CLINICAL TRIAL ANALYSIS
16.1. Chapter Overview
16.2. Scope and Methodology
16.3. Medical Devices: Clinical Trial Analysis
16.3.1. Analysis by Trial Registration Year
16.3.2. Analysis of Trial Status
16.3.3. Analysis by Patient Gender Recruited
16.3.4. Analysis of Target Patient Population
16.3.5. Analysis by Study Design
16.3.5.1. Analysis by Type of Intervention Model
16.3.5.2. Analysis by Type of Masking
16.3.5.3. Analysis by Trial Purpose
16.3.6. Analysis by Type of Sponsor / Collaborator
16.3.7. Leading Industry Players: Analysis by Number of Clinical Trials
16.3.8. Analysis by Geography
16.3.8.1. Analysis of Clinical Trials by Geography
16.3.8.2. Analysis of Patients Enrolled by Geography and Trial Status
17. CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING
17.1. Chapter Overview
17.2. Emerging Markets: Definitions and Key Regions
17.3. Role of Emerging Markets in Industrial Manufacturing
17.3.1. Contributions to the Automobile Industry
17.3.2. Contributions to the Aerospace and Defense Industries
17.4. Medical Devices Manufacturing in Emerging Markets
17.4.1. The US-Chinese Scenario
17.4.2. Partnership with Companies in Emerging Markets
17.5. Multinational Companies Focused on Manufacturing Medical Devices in Emerging Markets
17.6. Business Models for Medical Device Manufacturing in Emerging Markets
17.6.1. Case Studies
17.6.1.1. Study A: Overview
17.6.1.1.1. Value Proposition
17.6.1.1.2. Value Creation
17.6.1.2. Study B: Overview
17.6.1.2.1. Value Proposition
17.6.1.2.2. Value Creation
17.7. Key Challenges related to Innovation in the Medical Device Industry
17.7.1. Limitations of In-House Innovation
17.8. Advantages of Establishing Innovation Hubs in Emerging Markets
17.8.1. Challenges and Market Restraints
17.8.2. Strategies to Address Existing Challenges
17.9. Future Perspectives
18. SWOT ANALYSIS
18.1. Chapter Overview
18.2. Strengths
18.3. Weaknesses
18.4. Opportunities
18.5. Threats
18.6. Concluding Remarks
19. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
19.1. Chapter Overview
19.2. Assumptions and Methodology
19.3. Roots Analysis Perspective on Market Growth
19.4. North America Medical Device Contract Manufacturing Market: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.4.1. Scenario Analysis
19.4.1.1. Conservative Scenario
19.4.1.2. Optimistic Scenario
20. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF MEDICAL DEVICE
20.1. Chapter Overview
20.2. Assumptions and Methodology
20.3. North America Medical Device Contract Manufacturing Market: Distribution by Class of Medical Device
20.3.1. North America Medical Device Contract Manufacturing Market for Class I Medical Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.3.2. North America Medical Device Contract Manufacturing Market for Class II Medical Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.3.3. North America Medical Device Contract Manufacturing Market for Class III Medical Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.4. Penetration-Growth (P-G) Matrix
20.5. Data Triangulation and Validation
21. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY TYPE OF MEDICAL DEVICE
21.1. Chapter Overview
21.2. Assumptions and Methodology
21.3. North America Medical Device Contract Manufacturing Market: Distribution by Type of Medical Device
21.3.1. North America Medical Device Contract Manufacturing Market for Therapeutic Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.3.2. North America Medical Device Contract Manufacturing Market for Diagnostic Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.3.3. North America Medical Device Contract Manufacturing Market for Drug Delivery Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.3.4. North America Medical Device Contract Manufacturing Market for Other Medical Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.4. Penetration-Growth (P-G) Matrix
21.5. Data Triangulation and Validation
22. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY THERAPEUTIC AREA
22.1. Chapter Overview
22.2. Assumptions and Methodology
22.3. North America Medical Device Contract Manufacturing Market: Distribution by Therapeutic Area
22.3.1. North America Medical Device Contract Manufacturing Market for Cardiovascular Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.2. North America Medical Device Contract Manufacturing Market for Orthopedic Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.3. North America Medical Device Contract Manufacturing Market for Metabolic Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.4. North America Medical Device Contract Manufacturing Market for Neurological Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.5. North America Medical Device Contract Manufacturing Market for Ophthalmological Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.6. North America Medical Device Contract Manufacturing Market for Respiratory Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.7. North America Medical Device Contract Manufacturing Market for Oncological Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.8. North America Medical Device Contract Manufacturing Market for Gastrological Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.3.9. North America Medical Device Contract Manufacturing Market for Other Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.4. Penetration-Growth (P-G) Matrix
22.5. Data Triangulation and Validation
23. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COMPANY SIZE
23.1. Chapter Overview
23.2. Assumptions and Methodology
23.3. North America Medical Device Contract Manufacturing Market: Distribution by Company Size
23.3.1. North America Medical Device Contract Manufacturing Market for Very Small Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
23.3.2. North America Medical Device Contract Manufacturing Market for Small Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
23.3.3. North America Medical Device Contract Manufacturing Market for Mid-sized Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
23.3.4. North America Medical Device Contract Manufacturing Market for Large Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
23.4. Penetration-Growth (P-G) Matrix
23.5. Data Triangulation and Validation
24. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY LEADING PLAYERS
25. CONCLUSION
26. EXECUTIVE INSIGHTS
26.1. Chapter Overview
26.2. Company A
26.2.1. Company Overview
26.2.2. Interview Transcript: Chief Research and Technology Director
26.3. Company B
26.3.1. Company Overview
26.3.2. Interview Transcript: Former President and Chief Executive Officer
26.4. Company C
26.4.1. Company Overview
26.4.2. Interview Transcript: Chief Executive Officer
26.5. Company D
26.5.1. Company Overview
26.5.2. Interview Transcript: Chief Operating Officer
26.6. Company E
26.6.1. Company Overview
26.6.2. Interview Transcript: Senior Vice President of Head of Commercial
26.7. Company F
26.7.1. Company Overview
26.7.2. Interview Transcript: Vice President Global Marketing and Commercial Operations
26.8. Company G
26.8.1. Company Overview
26.8.2. Interview Transcript: Senior Director Business Development Medical Device
26.9. Company H
26.9.1. Company Overview
26.9.2. Interview Transcript: Director of Business Development, Small Company, Sweden
26.10. Company I
26.10.1. Company Overview
26.10.2. Interview Transcript: Senior Account Manager
26.11. Company J
26.11.1. Company Overview
26.11.2. Interview Transcript: Technical Director and Partner
26.12. Company K
26.12.1. Company Overview
26.12.2. Interview Transcript: Assistant Manager
26.13. Company L
26.13.1. Company Overview
26.13.2. Interview Transcript: General Manager
26.14. Company M
26.14.1. Company Overview
26.14.2. Interview Transcript: Former Lead Trainer and QC Manager
26.15. Company N
26.15.1. Company Overview
26.15.2. Interview Transcript: Former Business Development Consultant
26.16. Company O
26.16.1. Company Overview
26.16.2. Interview Transcript: Former Research Study Assistant
27. APPENDIX I: TABULATED DATA
28. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS